BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1541528)

  • 1. Structure-function analysis of exotoxin A proteins with mutations at histidine 426.
    Wick MJ; Cook JM; Iglewski BH
    Infect Immun; 1992 Mar; 60(3):1128-39. PubMed ID: 1541528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.
    Lukac M; Collier RJ
    Biochemistry; 1988 Oct; 27(20):7629-32. PubMed ID: 2849995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical analysis of CRM 66. A nonfunctional Pseudomonas aeruginosa exotoxin A.
    Galloway DR; Hedstrom RC; McGowan JL; Kessler SP; Wozniak DJ
    J Biol Chem; 1989 Sep; 264(25):14869-73. PubMed ID: 2504713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa exotoxin A: alterations of biological and biochemical properties resulting from mutation of glutamic acid 553 to aspartic acid.
    Douglas CM; Collier RJ
    Biochemistry; 1990 May; 29(21):5043-9. PubMed ID: 1974145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
    Brandhuber BJ; Allured VS; Falbel TG; McKay DB
    Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553.
    Killeen KP; Collier RJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):162-6. PubMed ID: 1347236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a fluorometric assay for characterization of the catalytic competency of a domain III fragment of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Anal Biochem; 2001 May; 292(1):26-33. PubMed ID: 11319814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-evaluation of the role of histidine-426 within Pseudomonas aeruginosa exotoxin A.
    Roberts TM; Merrill AR
    Biochem J; 2002 Nov; 367(Pt 3):601-8. PubMed ID: 12160465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity.
    Wedekind JE; Trame CB; Dorywalska M; Koehl P; Raschke TM; McKee M; FitzGerald D; Collier RJ; McKay DB
    J Mol Biol; 2001 Dec; 314(4):823-37. PubMed ID: 11734000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the structure-function relationship of Pseudomonas aeruginosa exotoxin A.
    Wick MJ; Hamood AN; Iglewski BH
    Mol Microbiol; 1990 Apr; 4(4):527-35. PubMed ID: 2112672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical analysis of Pseudomonas aeruginosa exotoxin A. Analysis of the His426 determinant.
    McGowan JL; Kessler SP; Anderson DC; Galloway DR
    J Biol Chem; 1991 Mar; 266(8):4911-6. PubMed ID: 1705936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of exotoxin A-related protein of Pseudomonas aeruginosa lacking residues 225-412.
    Guidi-Rontani C
    FEMS Microbiol Lett; 1991 May; 64(1):103-9. PubMed ID: 1906825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC
    J Bacteriol; 1993 Feb; 175(3):898-901. PubMed ID: 8423159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of eliminating a disulfide bridge within domain II of Pseudomonas aeruginosa exotoxin A.
    Madshus IH; Collier RJ
    Infect Immun; 1989 Jul; 57(7):1873-8. PubMed ID: 2499539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.